Pricing Log in Create free account

Vyome Holdings, Inc. (HIND) vs Lisata Therapeutics, Inc. (LSTA)

Vyome Holdings, Inc. and Lisata Therapeutics, Inc. are both Biotechnology companies. Vyome Holdings, Inc. and Lisata Therapeutics, Inc. are of similar size ($11.4M and $10.7M). Lisata Therapeutics, Inc. grew revenue faster over the last twelve months: −24.7% against −67.1%. Lisata Therapeutics, Inc. has the higher net margin (0.00% vs −8,711.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Lisata Therapeutics, Inc. leads on 11 and Vyome Holdings, Inc. on 5.

Valuation

Metric HIND LSTA Biotechnology median
P/E n/m n/m 10.60
P/S 86.52 0.61 9.40
P/B 1.54 1.16 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 124.04 0.14 9.02
Earnings yield (223.64%) (160.78%) (32.88%)
Free cash flow yield (49.67%) (132.98%) (23.13%)

Profitability

Metric HIND LSTA Biotechnology median
Gross margin 52.77% 0.49% 68.51%
Operating margin (9,184.82%) 0.00% 0.00%
Net margin (8,711.71%) 0.00% 0.00%
Free cash flow margin (4,298.00%) 0.00% 0.00%
Return on equity (172.10%) (101.66%) (51.96%)
Return on assets (124.23%) (80.81%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric HIND LSTA Biotechnology median
Revenue growth (TTM) (67.10%) (24.67%) 6.76%
EPS growth (last fiscal year) 99.92% 20.42% 29.88%
Revenue growth, 5-year CAGR (50.98%) (20.28%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HIND LSTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.37 3.69 4.97
Net debt to EBITDA 0.48 0.88 1.01

Dividend

Metric HIND LSTA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric HIND LSTA Biotechnology median
Market cap 11.44m 10.71m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack